Nervonik

Designed For Motion

Nervonik is headquartered in Los Angeles, United States, lists 1–10 employees, and has $52.5M in recorded funding across 3 rounds.

Employees
1–10
Business Model
B2B
Total Funding
$52.5M
Last Round
$52.5M Series BApr 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Nervonik is developing next-generation peripheral nerve stimulation (PNS) technology featuring a novel, patented trifecta system that eliminates technical barriers to biosensing in high-motion applications. The company's miniaturized devices address limitations of existing PNS devices by improving lead placement, programming flexibility, energy efficiency, and long-term efficacy. Nervonik's technology is currently under development and has not yet received FDA clearance or approval.

Summary

Nervonik is a Healthcare company based in Los Angeles, United States. It lists 1–10 employees. It has raised $52.5M in total across 3 rounds, most recently a $52.5M Series B round in Apr 2026. Investors include US Venture Partners, ShangBay Capital and Camford Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2026
$52.5M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nervonik on Indexed.vc
<a href="https://indexed.vc/companies/nervonik"><img src="https://indexed.vc/api/badge/company/nervonik" alt="Nervonik on Indexed.vc" width="260" height="76" /></a>